GaryICohenMD

Oncology • Baltimore, MD

Physician

Join to view full profile

Dr. Cohen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Cohen's full profile

Already have an account?

Office
6569 N Charles St
Suite 201
Baltimore, MD 21204
Phone+1 443-849-3051

Fax+1 443-849-3057
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1978 - 1980
University at BuffaloResidency, Internal Medicine, 1976 - 1978
University at BuffaloInternship, Internal Medicine, 1975 - 1976
University of Maryland School of MedicineClass of 1975

Certifications & Licensure

MD State Medical License 1982 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2011-2014
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18
Active, not recruiting
Phase 2
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
Active, not recruiting
Phase 2
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma Start of enrollment: 2013 Dec 01
Terminated
Phase 2

Publications & Presentations

PubMed

102 citations
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Atkins, M., Lee, S., Chmielowski, B., Tarhini, A., Cohen, G., Truong, T., Moon, H., Davar, D., O'Rourke, M., Stephenson, J., Curti, B., Urba, W., Brell, J., Funchain, ...> ;Journal of Clinical Oncology. 2023 Jan 10
5 citations
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
Jennifer Y. Sheng, Cesar A. Santa-Maria, Amanda L. Blackford, David Lim, Ashley Carpenter, Karen L. Smith, Gary I. Cohen, Janelle W. Coughlin, Lawrence J. Appel, Vered...> ;Journal of Cancer Survivorship. 2021 May 20
10 citations
Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis.
Ahmad A. Tarhini, Ni Kang, Sandra J. Lee, F. Stephen Hodi, Gary I. Cohen, Omid Hamid, Laura F. Hutchins, Jeffrey A. Sosman, Harriet M. Kluger, Zeynep Eroglu, Henry B. ...> ;Journal for Immunotherapy of Cancer. 2021 May 1
91 citations
Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609
Ahmad A. Tarhini, Sandra J. Lee, F. Stephen Hodi, Uma N. M. Rao, Gary I. Cohen, Omid Hamid, Laura F. Hutchins, Jeffrey A. Sosman, H. Kluger, Zeynep Eroglu, Henry B. Ko...> ;Journal of Clinical Oncology. 2020 Feb 20
16 citations
The Effects of a Remote-Based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
Cesar A. Santa-Maria, Janelle W. Coughlin, Dipali Sharma, Mary Armanios, Amanda L. Blackford, Colleen C. Schreyer, Arlene Dalcin, Ashley Carpenter, Gerald J. Jerome, D...> ;Clinical Cancer Research. 2020 Feb 18
30 citations
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).
Lisa H. Butterfield, Fengmin Zhao, Sandra J. Lee, Ahmad A. Tarhini, Kim Margolin, Richard L. White, Michael B. Atkins, Gary I. Cohen, Theresa L. Whiteside, John M. Kir...> ;Clinical Cancer Research. 2017 Sep 1
75 citations
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E...
Kevin Kalinsky, Sandra J. Lee, Krista M. Rubin, Donald P. Lawrence, Anthony J. Iafrarte, Darell R. Borger, Kim Margolin, Mario M. Leitao, Ahmad A. Tarhini, Henry B. Ko...> ;Cancer. 2017 Jul 15
36 citations
Phase III randomized study of 4 weeks of high-dose interferon-α-2b in stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) melanoma: A trial of the Eastern Coop...
Sanjiv S. Agarwala, Sandra J. Lee, Wai-Ki Yip, Uma N. M. Rao, Ahmad A. Tarhini, Gary I. Cohen, Douglas S. Reintgen, Terry L. Evans, Joanna M. Brell, Mark R. Albertini,...> ;Journal of Clinical Oncology. 2017 Jan 30
72 citations
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plu...
David H. Lawson, Sandra J. Lee, Fengmin Zhao, Ahmad A. Tarhini, Kim Margolin, Marc S. Ernstoff, Michael B. Atkins, Gary I. Cohen, Theresa L. Whiteside, Lisa H. Butterf...> ;Journal of Clinical Oncology. 2015 Sep 8
15 citations
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study...
Tomasz P. Srokowski, James Liebmann, Manuel Modiano, Gary I. Cohen, Barbara Pro, Jorge E. Romaguera, Christine Kuepfer, Jack W. Singer, Luis Fayad> ;Cancer. 2011 Nov 15
Randomized phase III trial of high-dose interferon alfa-2b (HDI) for 4 weeks induction only in patients with intermediate- and high-risk melanoma (Intergroup trial E 1...
Agarwala SS, Lee SJ, Flaherty LE, Smylie M, Kefford RF, Carson WE, Cohen G, Kirkwood JM> ;J. Clin. Oncol.. 2011-05-20
1 citations
Part 2: implementing clinical trials: a review of the attributes of exemplary clinical trial sites.
Robin Zon, Gary Cohen, Dee Anna Smith, Allison R Baer> ;Journal of Oncology Practice. 2011 Jan 1
1 citations
Implementing clinical trials: a review of the attributes of exemplary clinical trial sites.
Allison R Baer, Gary Cohen, Dee Anna Smith, Robin Zon> ;Journal of Oncology Practice. 2010 Nov 1
9 citations
Basic Steps to Building a Research Program
Allison R. Baer, Naftali Bechar, Gary I. Cohen, Susan Devine> ;Journal of Oncology Practice. 2010 Jan 1
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
Hensley, M.L., Hagerty, K.L., Kewalramani, T., Green, D.M., Meropol, N.J., Wasserman, T.H., Cohen, G.I., Emami, B., Gradishar, W.J., Mitchell, R.B., Thigpen, J.T., Tro...> ;J Clin Oncol. 2009-01-01
First-in-human phase-I pharmacokinetic trial of NS-9, a liposomal poly(I):poly(C), in patients with liver metastases from various primary cancers.
Perez RP, Lewis LD, Cohen GI, Hwang J, Malik S, Marshall JL, Baker J, Phan AT, Yao JC, Ajani JA> ;J. Clin. Oncol.. 2006-06-20
254 citations
Exercise manages fatigue during breast cancer treatment: a randomized controlled trial
Victoria Mock, Constantine Frangakis, Nancy E. Davidson, Mary E. Ropka, Mary Pickett, Barbara Poniatowski, Kerry J. Stewart, Lane Cameron, Kristin L. Zawacki, Laura Je...> ;Psycho-Oncology. 2005 Jun 1
Phase II study of combination therapy with CHOP Interferon (IFN) alpha and rituximab (R) in chemo-naive patients (pts) with diffuse large B cell non-Hodgkin's lymphoma...
Rapoport BL, Slabber CF, Cohen G, McMichael G, Alberts AS, Vorobiof DA, Uys A> ;J. Clin. Oncol.. 2005-06-01
Phase 2 study of combination therapy with liposomal doxorubicin and carboplatin in patients with relapsed, platinum sensitive ovarian cancer.
Vorobiof DA, Rapoport B, Slabber C, Eek R, Cohen G, Alberts AS, McMichael GB, Raats J, Uys A> ;J. Clin. Oncol.. 2004-07-15
33 citations
The Satisfaction with Life Domains Scale for Breast Cancer (SLDS-BC).
Sarah Spagnola, James Zabora, Karlynn BrintzenhofeSzoc, Craig M. Hooker, Gary I. Cohen, Frank Baker> ;The Breast Journal. 2003 Nov 1
20 citations
Clinical research by community oncologists.
Gary I. Cohen> ;CA. 2003 Mar 1
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.
Pecora, A.L., Rizvi, N., Cohen, G.I., Meropol, N.J., Sterman, D., Marshall, J.L., Goldberg, S., Gross, P., O'Neil, J.D., Groene, W.S., Roberts, M.S., Rabin, H., Bamat,...> ;J Clin Oncol. 2002 May 1
24 citations
Chemotherapy-induced menopause: a literature review.
Barbara Poniatowski, Patricia Grimm, Gary I. Cohen> ;Cancer Investigation. 2001 Jul 31
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, Gradishar WJ, Green DM, Langdon RJ, Mitchell RB, Negrin R, Szatrowski TP, Thigpen JT, Von Hoff D, ...> ;J. Clin. Oncol.. 1999-10-01
5 citations
A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with...
Burton M. Needles, Eduardo Miranda, Francisco M. Garcia Rodriguez, Luis Baez Diaz, Jesse I. Spector, Johnny Craig, Gary I. Cohen, Steven H. Krasnow, Janice Brogden, Mi...> ;Supportive Care in Cancer. 1999 Sep 1
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Greater Baltimore Medical CenterTowson, Maryland
University of Maryland St. Joseph Medical CenterTowson, Maryland
Temple University HospitalPhiladelphia, Pennsylvania